NCT06173843 Occupational Exposures Among Firefighters
| NCT ID | NCT06173843 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vincere Cancer Center |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2023-12-06 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2023-12-06 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to understand the effect of occupational exposures, including PFAS exposures, among firefighters.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older; any gender * Currently (or previously) employed as a firefighter, full-time or part-time, participating in Vincere's First Responder Cancer Screening Program * Willing to provide a blood, urine, and/or tissue sample * Able to provide informed consent to participate in the study (A small group of non-firefighters will be enrolled to act as a comparison group)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06173843 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06173843 currently recruiting?
Yes, NCT06173843 is actively recruiting participants. Contact the research team at drlau@vincerecancer.com for enrollment information.
Where is the NCT06173843 trial being conducted?
This trial is being conducted at Scottsdale, United States.
Who is sponsoring the NCT06173843 clinical trial?
NCT06173843 is sponsored by Vincere Cancer Center. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.